Skip to main content
HLB bioStep Co.,Ltd. logo

HLB bioStep Co.,Ltd. — Investor Relations & Filings

Ticker · 278650 ISIN · KR7278650007 KO Professional, scientific and technical activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2022-01-13 Capital/Financing Update
Country KR South Korea
Listing KO 278650

About HLB bioStep Co.,Ltd.

http://hlbbiostep.com/en/

HLB bioStep Co.,Ltd. is a non-clinical Contract Research Organization (CRO) that provides a range of testing services to pharmaceutical companies and bio ventures. The company's core services support new drug development and include efficacy testing, pharmacokinetic/toxicokinetic (PK/TK) studies, and toxicology evaluations. A key area of specialization is veterinary medicine; HLB bioStep is an institution approved to conduct non-clinical tests and clinical trials for veterinary drugs. It also offers consulting services for regulatory approval procedures. The company utilizes various platform technologies, such as cell-enzyme-based screening and xenograft assays, and provides a comprehensive 'One-Stop Service' that leverages its experience in building laboratory facilities.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)(제2회차)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (Notus) detailing the results of a private placement of convertible bonds (증권 발행결과). It specifies the type of security, the issuance amount (26.5 billion KRW), and the payment date. This falls under the category of capital and financing updates as it relates to the company's capital structure and debt financing activities.
2022-01-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on the Status of Large Shareholdings' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of a significant stake (18.37%) in the company 'Notus' by 'HLB Co., Ltd.' through a stock and management rights transfer agreement. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks changes in significant ownership levels that cross regulatory reporting thresholds.
2022-01-03 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required when an entity or individual acquires a significant stake (typically 5% or more) in a publicly traded company. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification' (MRQ), which tracks changes in significant ownership levels.
2021-12-30 Korean
[첨부추가]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company (Knotus) detailing the issuance of convertible bonds (전환사채권 발행결정). It includes specific terms of the bond, such as interest rates, conversion prices, put/call options, and the use of proceeds. This type of filing is a standard regulatory disclosure for capital structure changes and financing activities in the Korean market, which falls under the 'Capital/Financing Update' category.
2021-12-28 Korean
[첨부추가]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from the company Knotus, specifically detailing the decision to issue convertible bonds (전환사채권 발행결정). This type of filing is a standard regulatory disclosure in the Korean market regarding capital structure changes and financing activities. Since it details the issuance of debt instruments that can be converted into equity, it falls under the 'Capital/Financing Update' category.
2021-12-28 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and a subsequent correction (정정신고) for the company Knotus (주식회사 노터스). This type of filing is a standard regulatory disclosure in the Korean market (DART system) concerning capital structure changes and financing activities. Since it details the terms of a convertible bond issuance, it falls under the 'Capital/Financing Update' category.
2021-12-28 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.